SecBot SecBot
SECBOTREPLAY Home › Report › MDGL

MDGL · Seven insiders at Madrigal Pharmaceuticals, including the CEO, CFO, and…

MADRIGAL PHARMACEUTICALS, INC. · CLUSTER filed Mar 2, 2026 at 17:32 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Mar 2, 2026 at 17:32 ET

Seven insiders at Madrigal Pharmaceuticals, including the CEO, CFO, and other C-suite executives, conducted open-market sales and stock awards within a 7-day window. The total value of open-market sales was approximately $2.37 million, representing modest insider selling activity at a company with a $10.1 billion market cap.

  • CEO William Sibold sold $718,316 worth of shares in open-market transactions on March 6, 2026.
  • CFO Mardi Dier sold $505,389 worth of shares on March 2, 2026.
  • Four other C-suite executives sold shares totaling $1.15 million on March 6.
  • Five insiders received non-cash stock awards totaling 27,375 shares on March 4, 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access